M

oderna Therapeutics, a multibillion-dollar biotech startup, is raising $500 million in a round that values the company at $7.5 billion, according to the data provider Pitchbook.

The financing, first reported by Bloomberg, comes as Moderna burns through about $450 million a year in an effort to craft medicines that can transform the body’s cells into drug factories. The company has raised more than $1.5 billion since its inception in 2010, repeatedly putting off a public offering as it worked through setbacks that delayed its most ambitious science.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • You continue to be the Sean Hannity of biotech quasi journalism. Spin for the win dude. Maybe you’re right, this whole thing at Moderna is a multibillion dollar scam.. Unfortunately, they are not Theranos, this is not and never was investigative journalism and there is no Pulitzer on the horizon.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.